Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study
- Author
- Wim Ceelen (UGent) , Louis Sandra (UGent) , Leen Van de Sande, Martin Graversen, An Vermeulen (UGent) , Dries Reynders (UGent) , Sarah Cosyns (UGent) , Anne Hoorens (UGent) and Wouter Willaert (UGent)
- Organization
- Keywords
- Cancer Research, Oncology
Downloads
-
2020 ASCO PTX.pdf
- full text (Published version)
- |
- open access
- |
- |
- 377.86 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8710630
- MLA
- Ceelen, Wim, et al. “Intraperitoneal Aerosolized Nanoparticle Albumin Based Paclitaxel (NAB-PTX) for Irresectable Peritoneal Metastases : A First in Human Phase I Study.” JOURNAL OF CLINICAL ONCOLOGY, vol. 39, no. Supplement 15, 2021, pp. 4065–4065, doi:10.1200/jco.2021.39.15_suppl.4065.
- APA
- Ceelen, W., Sandra, L., Van de Sande, L., Graversen, M., Vermeulen, A., Reynders, D., … Willaert, W. (2021). Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study. JOURNAL OF CLINICAL ONCOLOGY, 39(Supplement 15), 4065–4065. https://doi.org/10.1200/jco.2021.39.15_suppl.4065
- Chicago author-date
- Ceelen, Wim, Louis Sandra, Leen Van de Sande, Martin Graversen, An Vermeulen, Dries Reynders, Sarah Cosyns, Anne Hoorens, and Wouter Willaert. 2021. “Intraperitoneal Aerosolized Nanoparticle Albumin Based Paclitaxel (NAB-PTX) for Irresectable Peritoneal Metastases : A First in Human Phase I Study.” In JOURNAL OF CLINICAL ONCOLOGY, 39:4065–4065. https://doi.org/10.1200/jco.2021.39.15_suppl.4065.
- Chicago author-date (all authors)
- Ceelen, Wim, Louis Sandra, Leen Van de Sande, Martin Graversen, An Vermeulen, Dries Reynders, Sarah Cosyns, Anne Hoorens, and Wouter Willaert. 2021. “Intraperitoneal Aerosolized Nanoparticle Albumin Based Paclitaxel (NAB-PTX) for Irresectable Peritoneal Metastases : A First in Human Phase I Study.” In JOURNAL OF CLINICAL ONCOLOGY, 39:4065–4065. doi:10.1200/jco.2021.39.15_suppl.4065.
- Vancouver
- 1.Ceelen W, Sandra L, Van de Sande L, Graversen M, Vermeulen A, Reynders D, et al. Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study. In: JOURNAL OF CLINICAL ONCOLOGY. 2021. p. 4065–4065.
- IEEE
- [1]W. Ceelen et al., “Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study,” in JOURNAL OF CLINICAL ONCOLOGY, Online, 2021, vol. 39, no. Supplement 15, pp. 4065–4065.
@inproceedings{8710630, author = {{Ceelen, Wim and Sandra, Louis and Van de Sande, Leen and Graversen, Martin and Vermeulen, An and Reynders, Dries and Cosyns, Sarah and Hoorens, Anne and Willaert, Wouter}}, booktitle = {{JOURNAL OF CLINICAL ONCOLOGY}}, issn = {{0732-183X}}, keywords = {{Cancer Research,Oncology}}, language = {{eng}}, location = {{Online}}, number = {{Supplement 15}}, pages = {{4065--4065}}, title = {{Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study}}, url = {{http://doi.org/10.1200/jco.2021.39.15_suppl.4065}}, volume = {{39}}, year = {{2021}}, }
- Altmetric
- View in Altmetric